BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...


Reneo Pharmaceuticals is a clinical-stage start-up company, co-founded by Pappas Capital, focused on developing treatments for rare metabolic disorders